This bill proposes comprehensive changes to Minnesota's cannabis regulations, particularly concerning the sale of hemp-derived cannabinoids and medical cannabis provisions. It amends various sections of Minnesota Statutes, replacing the term "commissioner" with "office" to reflect a shift in oversight responsibilities to the Office of Cannabis Management. The bill introduces new definitions for terms related to medical cannabis and tribal programs, clarifies the roles of health care practitioners, and establishes guidelines for patient registry processes. Additionally, it sets limits on delta-9 tetrahydrocannabinol in edible products and emphasizes the importance of informing patients about clinical trials and the risks of medical cannabis use.

The legislation also enhances operational standards for medical cannabis manufacturers, including secure cultivation and processing requirements, and mandates monthly reporting to the office. It strengthens protections for individuals in the medical cannabis registry, prohibiting discrimination based on their status as users. The bill introduces new licensing categories for lower-potency hemp edible businesses, establishes specific application fees, and outlines compliance requirements for retailers. Overall, the bill aims to create a more robust regulatory framework for cannabis and hemp products in Minnesota, ensuring safety, compliance, and support for medical cannabis users while integrating tribal regulations into the state framework.

Statutes affected:
Introduction: 151.72, 342.01, 342.46
1st Engrossment: 152.22, 152.24, 152.25, 152.26, 152.261, 152.27, 152.28, 152.29, 152.31, 152.32, 152.33, 152.35, 152.37, 342.01, 342.02, 342.09, 342.51, 342.515, 342.52, 342.57, 342.59, 342.12, 342.14, 342.151, 342.17, 342.22, 342.28, 342.29, 342.30, 342.32, 342.33, 342.36, 342.37, 342.43, 342.61, 342.63, 151.72, 342.10, 342.11, 342.13, 342.18, 342.34, 342.39, 342.44, 342.45, 342.46, 342.62, 342.65, 342.66